A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1998
10/15/1998	CA2286283A1 Human gtp binding protein
10/15/1998	CA2286264A1 Insulin-like growth factor agonist peptides
10/15/1998	CA2285976A1 Method for inactivating pathogens, especially viruses, in a biological material
10/15/1998	CA2285960A1 Use of lactoferin in the treatment of allergen induced disorders
10/15/1998	CA2285933A1 Assay for ligands to tyrosine kinase receptors
10/15/1998	CA2285906A1 Hydroxamic acid derivatives
10/15/1998	CA2285605A1 Fanconi-gene ii
10/15/1998	CA2285336A1 Cosmetic and/or dermatological composition containing a derivative of methylated silanol and a derivative of hydrolysed plant protein
10/15/1998	CA2285235A1 Improved process for the manufacture of collagen
10/15/1998	CA2285020A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/15/1998	CA2284922A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
10/15/1998	CA2281843A1 Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
10/15/1998	CA2232861A1 Cdna clone hacch94 that encodes a novel human 7-transmembrane receptor
10/14/1998	EP0870831A1 Histidine kinase polypeptides
10/14/1998	EP0870830A2 Chimera hepatitis C virus antigen
10/14/1998	EP0870829A2 Staphylococcus aureus cell division gene Div1B
10/14/1998	EP0870828A1 NOVEL POLYPEPTIDE ORIGINATING IN $i(HEMOPHILUS PARAGALLINARUM) AND PROCESS FOR PRODUCING THE SAME
10/14/1998	EP0870827A2 Tumor necrosis factor related receptor, TR6
10/14/1998	EP0870826A1 Novel protein and monoclonal antibody specific thereto
10/14/1998	EP0870825A1 Human protein kinases hYAK3
10/14/1998	EP0870509A1 Sugar chain-recognizing antibody and remedy for infection with hiv
10/14/1998	EP0870506A1 Compositions comprising a cryptophycin compound in combination with a synchronizing or activating agent for treating cancer
10/14/1998	EP0870198A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
10/14/1998	EP0870049A2 Complementary adenoviral vector systems and cell lines
10/14/1998	EP0870040A2 Gene delivery vehicle-targeting ligands
10/14/1998	EP0870039A1 Recombinant fusion proteins to growth hormone and serum albumin
10/14/1998	EP0870038A1 INTERLEUKIN-1$g(b) CONVERTING ENZYME LIKE CYSTEINE PROTEASE
10/14/1998	EP0870036A1 SYNTHETIC MAMMALIAN $g(a)-N-ACETYLGLUCOSAMINIDASE AND GENETIC SEQUENCES ENCODING SAME
10/14/1998	EP0870035A2 A novel protein kinase required for ras signal transduction
10/14/1998	EP0870034A1 Novel nagpu
10/14/1998	EP0870033A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors
10/14/1998	EP0870032A2 Novel polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy
10/14/1998	EP0870030A1 Polypeptides with interleukin 16 activity, process for the preparation and use thereof
10/14/1998	EP0870028A1 Nucleic acids encoding interferon gamma inducing factor-2
10/14/1998	EP0870027A1 Novel c-mpl receptor agonists
10/14/1998	EP0870026A1 Ob protein derivatives having prolonged half-life
10/14/1998	EP0870024A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/14/1998	EP0870023A1 Osteoprotegerin
10/14/1998	EP0870020A2 Ligand polypeptides for the g-protein-coupled receptor protein, their production and use
10/14/1998	EP0870018A1 Antitumour vector constructs and methods
10/14/1998	EP0869976A1 Design of hormone-like antibodies with agonistic and antagonistic functions
10/14/1998	EP0869975A1 Assay for and uses of peptide hormone receptor ligands
10/14/1998	EP0869974A1 Compounds with growth hormone releasing properties
10/14/1998	EP0869973A2 Mammalian chemokine ccf8 and chemokine receptor cckr3
10/14/1998	EP0869972A1 Chemokine from niddm pancreas
10/14/1998	EP0869971A1 Two component signal transducing system protein from staphylococcus aureus
10/14/1998	EP0869970A1 Endothelial cell proliferation inhibitor and method of use
10/14/1998	EP0869969A1 Peptide conjugates, use thereof as a drug, and compositions containing same
10/14/1998	EP0869968A1 Growth-hormone secretagogues
10/14/1998	EP0869967A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
10/14/1998	EP0869966A1 Prodrugs of thrombin inhibitors
10/14/1998	EP0869818A1 Cytotoxic agents
10/14/1998	EP0869816A1 Dry compositions
10/14/1998	EP0869815A1 Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells
10/14/1998	EP0869813A1 Method of using beta-interferons to treat restenosis
10/14/1998	EP0869812A1 C-c chemokines that inhibit retrovirus infection
10/14/1998	EP0869811A1 Immunologically active mistletoe extract preparations
10/14/1998	EP0869810A1 Cyclosporin-containing soft capsule preparations
10/14/1998	EP0869809A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
10/14/1998	EP0869808A1 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
10/14/1998	EP0869805A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications
10/14/1998	EP0869804A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
10/14/1998	EP0869802A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions
10/14/1998	EP0869798A1 Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)
10/14/1998	EP0869788A1 Compositions for the treatment of renal failure, comprising l-carnosine
10/14/1998	EP0869774A1 Sustained release particles
10/14/1998	EP0769932B1 Implanted device containing tumor cells for the treatment of cancer
10/14/1998	EP0764273B1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
10/14/1998	EP0750493B1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide
10/14/1998	EP0741743B1 Cyclic neurokinin a antagonists
10/14/1998	EP0673388B1 Double chain peptide compounds having hemoregulatory activity
10/14/1998	EP0665887B1 Human 5-ht 2? receptor
10/14/1998	EP0628054B1 Car receptors and related molecules and methods
10/14/1998	CN1196087A Novel protein HMW human MP52
10/14/1998	CN1196086A Enamel matrix related polypeptide
10/14/1998	CN1196061A Insulin derivatives
10/14/1998	CN1196060A Cyclic hexapeptide compounds
10/14/1998	CN1195995A Transcytosis vehicles and enhancers for drug delivery
10/14/1998	CN1195992A Method and composition for enhanced parenteral nutrition
10/14/1998	CN1195983A Method of treatment for EIPH in racing stock
10/14/1998	CN1195982A Fgfr 3 as marker for mesenchymal skelftal progenitor cells
10/14/1998	CN1195664A New benzoxazinedione derivatives, method of producing them and use thereof
10/14/1998	CN1195525A Melatonin slow-releasing agent and its production process
10/14/1998	CN1040212C Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions
10/14/1998	CN1040178C Complement inhibitor for preparing drug for promoting transplantation survival or eliminating rejection
10/13/1998	US5821623 First metal silicide layer selected from tungsten, tintanium, tantalum and molybdenum having first stoichiometry and second metal silicide layer having second stoichiometry
10/13/1998	US5821353 DNA encoding 1,3 beta-D glucan synthase subunits
10/13/1998	US5821351 Chimeric human globin gene
10/13/1998	US5821341 Antibodies to sICAM-1
10/13/1998	US5821339 Compositions and methods for treatment of herpesvirus infections
10/13/1998	US5821337 Immunoglobulin variants
10/13/1998	US5821336 Polypeptide having specified amino acid sequence or fragment thereof
10/13/1998	US5821335 Biosynthetic gene murg from streptococcus pneumoniae
10/13/1998	US5821333 Method for making heteromultimeric polypeptides
10/13/1998	US5821332 Isolated receptor polypeptide having specified amino acid sequence; modulating immune response
10/13/1998	US5821331 Inhibit the proteolytic activity of proteases
10/13/1998	US5821329 Cyclic peptide inhibitors of β1 and β2 integrin-mediated adhesion
10/13/1998	US5821262 Hydroxamic acid derivatives as inhibitors of cytokine production
10/13/1998	US5821238 Administering to patient to impair tumor growth
10/13/1998	US5821234 Administering an effective dosage of at least one antisense sequence to at least one gene expressing a cyclin or a cyclin dependent kinase which inhibits the expression of the gene

1 ... 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 ... 3163